Skip to content

Codeine/​Chlorpheniramine/​Phenylephrine

    DEA Class; Rx

    Common Brand Names; Novahistine DH

    • Antitussives, Narcotic Combos

    Dihydrocodeine: Narcotic agonist analgesic with antitussive activity, mu receptor agonist

    Chlorpheniramine: Histamine H1-receptor antagonist

    Phenylephrine: Alpha-adrenergic stimulator with weak beta-adrenergic activity; produces systemic vasoconstriction of arteries and arterioles.

    Indicated for the treatment of  Cough and Congestion

    Codeine

    • Hypersensitivity

    • Acute abdominal condition, diarrhea associated w/ toxins, pseudomembranous colitis, respiratory depression

    • Asthma (acute), inflammatory bowel disease, respiratory impairment

    Chlorpheniramine

    • Acute asthma, sleep apnea

    Phenylephrine

    • Hypsesensitivity

    • Severe HTN, severe CAD

    • Within 14 days of nonselective MAO inhibitor therapy (risk of hypertensive reaction)

    • Newborn, preemies

    Codeine

    • Bradycardia, hypotension, tachycardia

    • Confusion, dizziness, false feeling of well being, headache, lightheadedness, malaise, paradoxical CNS stimulation, restlessness, weakness

    • Rash, urticaria

    • Anorexia, nausea, vomiting, xerostomia

    • LFT’s increased

    • Ureteral spasm, urination decreased

    • Dyspnea

    • Burning at injection site, blurred vision, histamine release

    Chlorpheniramine

    • Anticholinergic

    • Somnolence

    • Constipation

    • Diarrhea

    • Nausea

    • Vomiting

    • Blurred vision

    Codeine

    • Hypotension, with IV use

    • Seizure, with excessive doses

    • Anaphylactoid reaction (rare)

    • Respiratory depression

    Phenylephrine

    • Hypertension

    • Severe peripheral and visceral vasoconstriction

    • Pallor

    • Reflex tachycardia

    • Anxiety

    • Dizziness

    • Headache

    • Insomnia,Nervousness

    • Restlessness

    • Metabolic acidosis

    • Gastric irritation

    • Nausea

    • Decreased renal perfusion

    • Extravasation of IV administration may lead to necrosis and sloughing of surrounding tissue

    • Excitability

    Codeine

    • Cardiac arrhythmias, drug abuse/dependence, emotional lability, gallbladder disease, head injury, hepatic impairment, hypothyroidism, increased ICP, prostatic hypertrophy, renal impairment, seizures with epilepsy, urethral stricture, urinary tract surgery

    • Risk of life threatening side effects in nursing babies, especially if mother is an ultra rapid metabolizer of codeine

    • Ibuprofen is more effective than codeine for pain from musculoskeletal injuries in children

    Chlorpheniramine

    • May cause CNS depression (patient should not operate heavy machinery

    • Caution in patients with asthma, thyroid dysfunction, hypertension, ischemic heart disease, increased intraocular pressure, or prostatic hyperplasia/urinary obstruction

    Phenylephrine

    • Caution in diabetes mellitus, cardiovascular disease, prostatic hyperplasia, hyperthyroidism, and increased intraocular pressure

    Pregnancy category: C

    Not known whether distributed in breast milk, use caution

    Adults

    5-10 mL PO q4-6hr, up to 40 mL/24 hr

    Pediatric

    < 2 years: Not recommended

    2-6 years: 1.25-2.5 mL PO q4-6hr PRN, up to 10 mL/24 hr

    6-12 years: 2.5-5 mL PO q4-6hr, up to 20 mL/24 hr

    >12 years: 5-10 mL PO q4-6hr, up to 40 mL/24 hr

    Dihydrocodeine/chlorpheniramine/phenylephrine

    oral liquid: Schedule III

    • (7.5mg/2mg/5mg)/5mL

    oral syrup: Schedule V

    • (3mg/2mg/7.5mg)/5mL
    • (3mg/5mg/20mg)/5mL